ATP4A
Potassium-transporting ATPase alpha chain 1
Also known as: ATP4A_HUMAN, ATP6A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P20648
- Gene
- ATP4A
- Ensembl
- ENSG00000105675
- Chromosome
- 19
- Canonical length
- 1035 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene belongs to a family of P-type cation-transporting ATPases. The gastric H+, K+-ATPase is a heterodimer consisting of a high molecular weight catalytic alpha subunit and a smaller but heavily glycosylated beta subunit. This enzyme is a proton pump that catalyzes the hydrolysis of ATP coupled with the exchange of H(+) and K(+) ions across the plasma membrane. It is also responsible for gastric acid secretion. This gene encodes a catalytic alpha subunit of the gastric H+, K+-ATPase. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1035 residues, UniProt reviewed canonical sequence.
>P20648|ATP4A
1 MGKAENYELY SVELGPGPGG DMAAKMSKKK KAGGGGGKRK EKLENMKKEM EINDHQLSVA
61 ELEQKYQTSA TKGLSASLAA ELLLRDGPNA LRPPRGTPEY VKFARQLAGG LQCLMWVAAA
121 ICLIAFAIQA SEGDLTTDDN LYLAIALIAV VVVTGCFGYY QEFKSTNIIA SFKNLVPQQA
181 TVIRDGDKFQ INADQLVVGD LVEMKGGDRV PADIRILAAQ GCKVDNSSLT GESEPQTRSP
241 ECTHESPLET RNIAFFSTMC LEGTVQGLVV NTGDRTIIGR IASLASGVEN EKTPIAIEIE
301 HFVDIIAGLA ILFGATFFIV AMCIGYTFLR AMVFFMAIVV AYVPEGLLAT VTVCLSLTAK
361 RLASKNCVVK NLEAVETLGS TSVICSDKTG TLTQNRMTVS HLWFDNHIHT ADTTEDQSGQ
421 TFDQSSETWR ALCRVLTLCN RAAFKSGQDA VPVPKRIVIG DASETALLKF SELTLGNAMG
481 YRDRFPKVCE IPFNSTNKFQ LSIHTLEDPR DPRHLLVMKG APERVLERCS SILIKGQELP
541 LDEQWREAFQ TAYLSLGGLG ERVLGFCQLY LNEKDYPPGY AFDVEAMNFP SSGLCFAGLV
601 SMIDPPRATV PDAVLKCRTA GIRVIMVTGD HPITAKAIAA SVGIISEGSE TVEDIAARLR
661 VPVDQVNRKD ARACVINGMQ LKDMDPSELV EALRTHPEMV FARTSPQQKL VIVESCQRLG
721 AIVAVTGDGV NDSPALKKAD IGVAMGIAGS DAAKNAADMI LLDDNFASIV TGVEQGRLIF
781 DNLKKSIAYT LTKNIPELTP YLIYITVSVP LPLGCITILF IELCTDIFPS VSLAYEKAES
841 DIMHLRPRNP KRDRLVNEPL AAYSYFQIGA IQSFAGFTDY FTAMAQEGWF PLLCVGLRAQ
901 WEDHHLQDLQ DSYGQEWTFG QRLYQQYTCY TVFFISIEVC QIADVLIRKT RRLSAFQQGF
961 FRNKILVIAI VFQVCIGCFL CYCPGMPNIF NFMPIRFQWW LVPLPYGILI FVYDEIRKLG
1021 VRCCPGSWWD QELYYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP4A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 780 nTPM
Expression across tissuesHPA
Tissue
- stomach: 780 nTPM
- pancreas: 9.6 nTPM
- adrenal gland: 2.4 nTPM
- cerebral cortex: 0.6 nTPM
- cerebellum: 0.4 nTPM
- kidney: 0.3 nTPM
Single-cell type
- parietal cells: 4,248 nCPM
- gastric chief cells: 122 nCPM
- late spermatids: 32 nCPM
- pancreatic acinar cells: 18 nCPM
- mucous neck cells: 15 nCPM
- early spermatids: 9.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 2.6 nTPM
- cerebral cortex: 1.1 nTPM
- pons: 0.4 nTPM
- white matter: 0.3 nTPM
- basal ganglia: 0.2 nTPM
- midbrain: 0.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP4A.
Disease | AutoantibodyPubMed
Conditions in which antibodies against ATP4A are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for ATP4A from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
6 publications
- Luminescent Immunoprecipitation System (LIPS) for Detection of Autoantibodies Against ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase in Atrophic Body Gastritis Patients.
2017 · Clin Transl Gastroenterol · RCR 1.2 · 27 citations - Development of a novel autoantibody assay for autoimmune gastritis in type 1 diabetic individuals.
2011 · Diabetes Metab Res Rev · RCR 0.6 · 16 citations - ATP4A autoimmunity and Helicobacter pylori infection in children with type 1 diabetes.
2014 · Clin Exp Immunol · RCR 0.2 · 6 citations - ATP4A autoimmunity in pediatric patients with type 1 diabetes and its relationship to blood count, iron metabolism, and vitamin B12.
2018 · Pediatr Diabetes · RCR 0.2 · 5 citations - Autoantibodies against ATP4A are a feature of the abundant autoimmunity that develops in first-degree relatives of patients with type 1 diabetes.
2022 · Pediatr Diabetes · RCR 0.2 · 2 citations
Show 1 more
- Tumor necrosis factor alpha is not implicated in the genesis of experimental autoimmune gastritis.
2004 · J Autoimmun · RCR 0.1 · 8 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.87
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular potassium ion homeostasis
- intracellular sodium ion homeostasis
- monoatomic ion transmembrane transport
- pH reduction
- potassium ion import across plasma membrane
- potassium ion transmembrane transport
- proton transmembrane transport
- regulation of proton transport
- response to xenobiotic stimulus
- sodium ion export across plasma membrane
Molecular functions
- ATP binding
- ATP hydrolysis activity
- magnesium ion binding
- P-type potassium:proton transporter activity
- P-type sodium:potassium-exchanging transporter activity
- potassium ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-type ATPase
- Cation-transporting P-type ATPase, N-terminal
- P-type ATPase subfamily IIC, subunit alpha
- Cation-transporting P-type ATPase, C-terminal
- P-type ATPase, A domain superfamily
- P-type ATPase, phosphorylation site
- HAD superfamily
- P-type ATPase, transmembrane domain superfamily
- P-type ATPase, cytoplasmic domain N
- HAD-like superfamily
- P-type ATPase, haloacid dehalogenase domain
- Cation transport ATPase (P-type)
- P-type ATPase, A domain
- P-type ATPase actuator domain
- Cation transporting ATPase, C-terminus
- Cation transporter/ATPase, N-terminus
- haloacid dehalogenase-like hydrolase
- P-type ATPase, cytoplasmic domain N
- Gastric H+/K+-transporter P-type ATPase, N-terminal
- Gastric H+/K+-ATPase, N terminal domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP4A as an antibody target. Whether an autoantibody or antibody against ATP4A could matter depends on whether native ATP4A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP4A is annotated at the cell surface, where native ATP4A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ATP4A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...